Search Results - E. Rademaker
- Showing 1 - 3 results of 3
-
1
Treatment with curative intent for locoregional recurrent colon cancer – a systematic review by E. Rademaker, A. Stapasolla Vargas Garcia, I. H. J. Sujecki, R. M. Brohet, H. Swartjes, J. H. W. de Wilt, N. F. M. Kok, I. H. J. T. de Hingh, H. L. Van Westreenen, E. C. J. Consten, P. J. Tanis
Published in BMC Surgery (2025-10-01)Get full text
Article -
2
The effect of immunosuppressive therapies on the endothelial host response in critically ill COVID-19 patients by M. A. Slim, E. H. T. Lim, L. A. van Vught, A. M. Tuip-de Boer, E. Rademaker, J. L. G. Haitsma Mulier, J. J. Engel, The Amsterdam UMC COVID-19 Biobank Study Group, The Radboudumc Center for Infectious Diseases COVID-19 Study Group, P. Pickkers, F. L. van de Veerdonk, A. P. J. Vlaar, L. P. G. Derde, N. P. Juffermans
Published in Scientific Reports (2024-04-01)Get full text
Article -
3
T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors by Suzanne I.M. Neppelenbroek, Yvonne M.G. Geurts, Berthe M. P. Aleman, Cécile P.M. Janus, Pieternella J. Lugtenburg, Saskia E. Rademaker, Roel J. De Weijer, Maaike G.A. Schippers, Bastiaan D.P. Ta, Wouter J. Plattel, Josée. M. Zijlstra, Richard W.M. Van Der Maazen, Marten R. Nijziel, Francisca Ong, Erik C. Schimmel, Eduardus F.M. Posthuma, Marie José Kersten, Lara H. Böhmer, Karin Muller, Harry R. Koene, Liane C.J. Te Boome, Yavuz M. Bilgin, Eva De Jongh, Flora E. Van Leeuwen, Michael Schaapveld
Published in HemaSphere (2022-10-01)Get full text
Article
